Advertisement

Loading...

Stem Holdings, Inc.

STEM.CNCNQ
Healthcare
Drug Manufacturers - Specialty & Generic
$0.31
$0.00(0.00%)
Canadian Market opens in 16h 37m

Stem Holdings, Inc. Fundamental Analysis

Stem Holdings, Inc. (STEM.CN) shows weak financial fundamentals with a PE ratio of -0.12, profit margin of 0.00%, and ROE of -2.75%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position30.77%
PEG Ratio-0.00

Areas of Concern

ROE-2.75%
Operating Margin0.00%
Current Ratio0.95
We analyze STEM.CN's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -295.8/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-295.8/100

We analyze STEM.CN's fundamental strength across five key dimensions:

Efficiency Score

Weak

STEM.CN struggles to generate sufficient returns from assets.

ROA > 10%
-1.42%

Valuation Score

Excellent

STEM.CN trades at attractive valuation levels.

PE < 25
-0.12
PEG Ratio < 2
-0.00

Growth Score

Weak

STEM.CN faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

STEM.CN shows balanced financial health with some risks.

Debt/Equity < 1
-1.36
Current Ratio > 1
0.95

Profitability Score

Weak

STEM.CN struggles to sustain strong margins.

ROE > 15%
-274.81%
Net Margin ≥ 15%
0.00%
Positive Free Cash Flow
No

Key Financial Metrics

Is STEM.CN Expensive or Cheap?

P/E Ratio

STEM.CN trades at -0.12 times earnings. This suggests potential undervaluation.

-0.12

PEG Ratio

When adjusting for growth, STEM.CN's PEG of -0.00 indicates potential undervaluation.

-0.00

Price to Book

The market values Stem Holdings, Inc. at -1.30 times its book value. This may indicate undervaluation.

-1.30

EV/EBITDA

Enterprise value stands at 0.00 times EBITDA. This is generally considered low.

0.00

How Well Does STEM.CN Make Money?

Net Profit Margin

For every $100 in sales, Stem Holdings, Inc. keeps $0.00 as profit after all expenses.

0.00%

Operating Margin

Core operations generate 0.00 in profit for every $100 in revenue, before interest and taxes.

0.00%

ROE

Management delivers $-2.75 in profit for every $100 of shareholder equity.

-2.75%

ROA

Stem Holdings, Inc. generates $-1.42 in profit for every $100 in assets, demonstrating efficient asset deployment.

-1.42%

Following the Money - Real Cash Generation

FCF Per Share

Each share generates $-0.12 in free cash annually.

$-0.12

FCF Yield

STEM.CN converts -3.21% of its market value into free cash.

-3.21%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.12

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.00

vs 25 benchmark

P/B Ratio

Price to book value ratio

-1.30

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.00

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-1.36

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.95

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-2.75

vs 25 benchmark

ROA

Return on assets percentage

-1.42

vs 25 benchmark

ROCE

Return on capital employed

5.94

vs 25 benchmark

How STEM.CN Stacks Against Its Sector Peers

MetricSTEM.CN ValueSector AveragePerformance
P/E Ratio-0.1227.91 Better (Cheaper)
ROE-274.81%687.00% Weak
Net Margin0.00%-45285.00% (disorted) Weak
Debt/Equity-1.360.33 Strong (Low Leverage)
Current Ratio0.952795.76 Weak Liquidity
ROA-142.49%-13557.00% (disorted) Weak

STEM.CN outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Stem Holdings, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ